Publications by authors named "Mike Youle"

Claim this Profile
V
Virologic and immunologic outcomes of treatment with integrase inhibitors in a real-world setting: The RESPOND cohort consortium.
Bastian Neesgaard, Amanda Mocroft, Robert Zangerle, Ferdinand Wit, Fiona Lampe, Mike Youle

PLoS One· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of HIV status on the frequency and severity of acute respiratory illness.
James Brown, Elisha Pickett, Colette Smith, Memory Sachikonye, Lucy Brooks, Mike Youle

PLoS One· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidemiological characteristics and access to end-stage liver disease care for HIV-positive patients with HCV and/or HBV coinfections in Central/Eastern European and neighboring countries – data from the ECEE network.
Agata Skrzat-Klapaczyńska, Bartłomiej Matłosz, Dan Otelea, Arjan Harxhi, Anna Vassilenko, Mike Youle

Przegl Epidemiol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Engagement in care among youth living with parenterally-acquired HIV infection in Romania.
Cosmina Gingaras, Colette Smith, Roxana Radoi, Diana Sima, Mike Youle

AIDS Care· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Choice of first-line antiretroviral therapy regimen and treatment outcomes for HIV in a middle income compared to a high income country: a cohort study.
Gordana Dragovic, Colette J Smith, Djordje Jevtovic, Bozana Dimitrijevic, Jovana Kusic, Mike Youle

BMC Infect Dis· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment intensification followed by interleukin-7 reactivates HIV without reducing total HIV DNA: a randomized trial.
Christine Katlama, Sidonie Lambert-Niclot, Lambert Assoumou, Laura Papagno, François Lecardonnel, Mike Youle

AIDS· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical relevance of the plasma load of cytomegalovirus in patients infected with HIV--a survival analysis.
Victoria Aramă, Raluca Mihăilescu, Mihaela Rădulescu, Sorin Ştefan Aramă, Adrian Streinu-Cercel, Mike Youle

J Med Virol· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of management strategies and clinical status on costs of care for advanced HIV.
Paul G Barnett, Adam Chow, Vilija R Joyce, Ahmed M Bayoumi, Susan C Griffin, Mike Youle

Am J Manag Care· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Higher risk of renal impairment associated with tenofovir use amongst people living with HIV in India: a comparative cohort analysis between Western India and United Kingdom.
Sanjay N Pujari, Colette Smith, Abhimanyu Makane, Mike Youle, Margaret Johnson

BMC Infect Dis· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2012 (Updated November 2013. All changed text is cast in yellow highlight.).

HIV Med· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lower healthcare costs associated with the use of a single-pill ARV regimen in the UK, 2004-2008.
Eduard J Beck, Sundhiya Mandalia, Roshni Sangha, Mike Youle, Ray Brettle

PLoS One· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimation of the effect of SLCO1B1 polymorphisms on lopinavir plasma concentration in HIV-infected adults.
Alessandro Schipani, Deirdre Egan, Laura Dickinson, Gerry Davies, Marta Boffito, Mike Youle

Antivir Ther· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2012.
Ian Williams, Duncan Churchill, Jane Anderson, Marta Boffito, Mark Bower, Mike Youle

HIV Med· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The cost-effectiveness of early access to HIV services and starting cART in the UK 1996-2008.
Eduard J Beck, Sundhiya Mandalia, Roshni Sangha, Peter Sharott, Mike Youle

PLoS One· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of treatment interruption and intensification of antiretroviral therapy on health-related quality of life in patients with advanced HIV: a randomized, controlled trial.
Vilija R Joyce, Paul G Barnett, Adam Chow, Ahmed M Bayoumi, Susan C Griffin, Mike Youle

Med Decis Making· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The use of computational models to predict response to HIV therapy for clinical cases in Romania.
Andrew D Revell, Luminiţa Ene, Dan Duiculescu, Dechao Wang, Mike Youle

Germs· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of early treatment with first-line NNRTI-based HAART regimens in the UK, 1996-2006.
Eduard J Beck, Sundhiya Mandalia, Gary Lo, Peter Sharott, Mike Youle

PLoS One· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rising population cost for treating people living with HIV in the UK, 1997-2013.
Sundhiya Mandalia, Roshni Mandalia, Gary Lo, Tim Chadborn, Peter Sharott, Mike Youle

PLoS One· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-related quality of life in a randomized trial of antiretroviral therapy for advanced HIV disease.
Vilija R Joyce, Paul G Barnett, Ahmed M Bayoumi, Susan C Griffin, Tassos C Kyriakides, Mike Youle

J Acquir Immune Defic Syndr· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
British HIV Association Guidelines for the treatment of HIV-1-infected adults with antiretroviral therapy 2008.
B G Gazzard, Jane Anderson, Abdel Babiker, Marta Boffito, Gary Brook, Mike Youle

HIV Med· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stability of antiretroviral regimens in patients with viral suppression.
Rebecca K Lodwick, Colette J Smith, Mike Youle, Fiona C Lampe, Mervyn Tyrer

AIDS· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TILT: a randomized controlled trial of interruption of antiretroviral therapy with or without interleukin-2 in HIV-1 infected individuals.
Brian Angus, Fiona Lampe, Guiseppe Tambussi, Claudine Duvivier, Christine Katlama, Mike Youle

AIDS· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overview of boosted protease inhibitors in treatment-experienced HIV-infected patients.
Mike Youle

J Antimicrob Chemother· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The influence of HIV infection and antiretroviral therapy on the mitochondrial membrane potential of peripheral mononuclear cells.
Thomas Sternfeld, Mathias Schmid, Annette Tischleder, Susanne Mudra, Angelika Schlamp, Mike Youle

Antivir Ther· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acetyl-L-carnitine in HIV-associated antiretroviral toxic neuropathy.
Mike Youle

CNS Drugs· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis